UNCY vs. MIST
UNCY (Unicycive Therapeutics Inc) and MIST (Milestone Pharmaceuticals Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 3 years, UNCY returned -19.69%/yr vs -30.18%/yr for MIST. At a 0.14 correlation, their price movements are largely independent.
Performance
UNCY vs. MIST - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, UNCY achieves a 24.78% return, which is significantly higher than MIST's -36.63% return.
UNCY
- 1D
- -0.41%
- 1M
- -9.77%
- YTD
- 24.78%
- 6M
- 16.69%
- 1Y
- -5.64%
- 3Y*
- -19.69%
- 5Y*
- —
- 10Y*
- —
MIST
- 1D
- -3.03%
- 1M
- -32.45%
- YTD
- -36.63%
- 6M
- -51.15%
- 1Y
- -24.26%
- 3Y*
- -30.18%
- 5Y*
- -25.32%
- 10Y*
- —
UNCY vs. MIST - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
UNCY Unicycive Therapeutics Inc | 24.78% | -27.35% | -8.47% | 60.69% | -73.79% | -58.80% |
MIST Milestone Pharmaceuticals Inc. | -36.63% | -14.41% | 41.32% | -57.83% | -39.54% | 19.09% |
Correlation
The correlation between UNCY and MIST is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Jul 13, 2021 | 0.14 |
The correlation between UNCY and MIST shifts across timeframes, from 0.14 (all time) to 0.27 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
UNCY:
$1.72B
MIST:
$166.77M
UNCY:
-$0.37
MIST:
-$0.49
UNCY:
45.66
MIST:
4.63
UNCY:
$0.00
MIST:
$1.78M
UNCY:
$0.00
MIST:
$1.75M
UNCY:
-$35.07M
MIST:
-$63.04M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
UNCY vs. MIST — Risk / Return Rank
UNCY
MIST
UNCY vs. MIST - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Unicycive Therapeutics Inc (UNCY) and Milestone Pharmaceuticals Inc. (MIST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| UNCY | MIST | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.06 | -0.29 | +0.23 |
Sortino ratioReturn per unit of downside risk | 0.55 | 0.15 | +0.39 |
Omega ratioGain probability vs. loss probability | 1.08 | 1.02 | +0.06 |
Calmar ratioReturn relative to maximum drawdown | -0.10 | -0.37 | +0.27 |
Martin ratioReturn relative to average drawdown | -0.15 | -0.73 | +0.58 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| UNCY | MIST | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.06 | -0.29 | +0.23 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.33 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.27 | -0.28 | +0.01 |
Drawdowns
UNCY vs. MIST - Drawdown Comparison
The maximum UNCY drawdown since its inception was -95.97%, roughly equal to the maximum MIST drawdown of -97.60%. Use the drawdown chart below to compare losses from any high point for UNCY and MIST.
Loading charts...
Drawdown Indicators
| UNCY | MIST | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.97% | -97.60% | +1.63% |
Max Drawdown (1Y)Largest decline over 1 year | -58.44% | -65.76% | +7.32% |
Max Drawdown (3Y)Largest decline over 3 years | -86.82% | -83.68% | -3.14% |
Max Drawdown (5Y)Largest decline over 5 years | — | -93.13% | — |
Current DrawdownCurrent decline from peak | -87.69% | -95.29% | +7.60% |
Average DrawdownAverage peak-to-trough decline | -82.91% | -78.27% | -4.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 37.49% | 33.40% | +4.09% |
Volatility
UNCY vs. MIST - Volatility Comparison
Unicycive Therapeutics Inc (UNCY) has a higher volatility of 19.24% compared to Milestone Pharmaceuticals Inc. (MIST) at 17.85%. This indicates that UNCY's price experiences larger fluctuations and is considered to be riskier than MIST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| UNCY | MIST | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 19.24% | 17.85% | +1.39% |
Volatility (6M)Calculated over the trailing 6-month period | 45.99% | 58.81% | -12.82% |
Volatility (1Y)Calculated over the trailing 1-year period | 89.27% | 83.35% | +5.92% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 119.64% | 77.69% | +41.95% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 119.64% | 105.36% | +14.28% |
Dividends
UNCY vs. MIST - Dividend Comparison
Neither UNCY nor MIST has paid dividends to shareholders.
Financials
UNCY vs. MIST - Financials Comparison
This section allows you to compare key financial metrics between Unicycive Therapeutics Inc and Milestone Pharmaceuticals Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
UNCY and MIST have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
UNCY has higher volatility (19.24%) compared to MIST (17.85%). In terms of maximum drawdown, UNCY dropped -95.97% vs MIST's -97.60%.
UNCY currently has the higher Sharpe Ratio (-0.06 vs -0.29), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for UNCY and MIST
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer